News
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
Researchers followed 60,000 adults aged 40 and older—who took various types of antidiabetic medication—for seven years ...
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.
The brain busting side-effects of Ozempic-like fat jabs revealed – ‘slashing risk of silent killers’
THEY’VE been hailed as miracle weight-loss jabs – but the effects of Ozempic-style drugs could go far beyond the waistline. New research suggests these so-called “skinny pens” may also ...
A new scientific study has found that weight loss jabs such as Mounjaro and Ozempic can help protect against serious health issues like dementia ...
Gabapentin is routinely used to treat nerve pain and restless leg syndrome, but it might be riskier to our brain health than ...
There is currently no known cure for dementia, as Xu notes. But up to half of all dementia cases might be preventable, and scientists have identified over a dozen modifiable risk factors that ...
A new study found that semaglutides like Ozempic are linked to a lower risk of Alzheimer's disease and dementia. Below, a ...
A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...
New research suggests that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, might protect against dementia. More than 6 million Americans are diagnosed with dementia each ...
A new study of 60,000 people around the world is shedding light on the possible brain health benefits of popular weight-loss drugs like Ozempic and Wegovy, specifically for their potential to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results